Agenda – Digital Therapeutics Summit

  • Day One
  • Day Two

Day One

 Monday, November 4

8:45AM – 9:00AM

Co-Chairperson’s Opening Remarks
Joel Sangerman, Chief Commercial Officer, CLICK THERAPEUTICS
Ruchita Sinha, Former Senior Director of Investments, SANOFI VENTURES

9:00AM – 9:40AM

KEYNOTE ADDRESS
Take a Deep Dive: Change, Adoption, and Innovation in the Digital Therapeutics Industry

Jennifer Goldsack, Interim Executive Director, DIME SOCIETY

 MARKET ACCESS

9:40AM – 10:20AM

STAKEHOLDER PANEL
Digital Therapeutics: The NEW Commercial Model

Savan Devani, Founder and CEO, BIOTRILLION
Mette Dyhrberg, Founder and CEO, MYMEE
Colin Kealey, Vice President, Medical Affairs, NEUROSIGMA

10:20AM – 10:50AM

Networking Break

10:50AM – 11:30AM

Looking Ahead: Exploring Regulatory Pathways for Digital Therapeutics
Martin Culjat, SVP Scientific and Regulatory Affairs, DTHERA SCIENCES

11:30AM – 12:10PM

Leveraging a Digital Therapeutic Patient Platform: Managing and Treating Patients With Sanofi
Chris Wasden, Ed.D., Head, Pharma, HAPPIFYDTX

12:10PM – 1:10PM

Luncheon

1:10PM – 1:50PM

Lessons Learned: Partner With Clinicians for Digital Therapeutics Integration
Barbara Eichorst, Global Diabetes and Digital Therapeutics Clinical Liaison, VOLUNTIS
Laurel Fuqua, Executive VP and Chief Clinical Officer, MONARCH MEDICAL TECHNOLOGIES

 PARTNERSHIPS

1:50PM – 2:30PM

Lessons Learned: The Many Journeys to Partnership
Adam Kaufman, President and CEO, CANARY HEALTH

2:30PM – 3:00PM

Networking Break

3:00PM – 3:40PM

Partnering to Enable New Business Models: The Need for Novel Partnership Modalities
Vincent Hennemand, SVP, Corporate and Business Development, AKILI INTERACTIVE LABS
Yoshinori Satomi, Associate Director, Digital Intelligence Dept., SHIONOGI

3:40PM – 4:20PM

Collaborating With a Payer: Explore the Process From Medical Policy to Commercialization
Debra Reisenthel, Founding CEO, Freespira Digital Therapeutic, PALO ALTO HEALTH SCIENCES
Matthew Tucker, Director of Strategy and Innovation, HIGHMARK HEALTH

4:20PM – 5:00PM

Prescription Software Distribution and Reimbursement: Partnering for Success
Tom Doyle, Senior Vice President, Commercial Solutions, EVERSANA
Brent Vaughan, CEO, COGNOA


Day Two

 Tuesday, November 5

8:00AM – 8:45AM

Continental Breakfast

8:45AM – 9:00AM

Co-Chairpersons’ Recap of Day One
Joel Sangerman, Chief Commercial Officer, CLICK THERAPEUTICS
Ruchita Sinha, Former Senior Director of Investments, SANOFI VENTURES

9:00AM – 9:40AM

Strategic Partnerships: Establishing Necessary Ingredients To Successfully Improve Patient Outcomes With Digital Therapeutics
Owen McCarthy, Co-Founder and President, MEDRHYTHMS
Carlos Rodarte, SVP Life Sciences Strategy and Business Development, HEALTH CATALYST

 DATA & VALIDATION

11:00AM – 11:30AM

Networking Break

11:30AM – 12:10PM

Understanding Challenges and Creating Solutions: Build a Body of Clinical Evidence for Digital Solutions
Suzanne Sysko Clough, M.D., Chief Medical Officer, AMALGAMRX
Ryan Sysko, CEO, AMALGAMRX

12:10PM – 12:50PM

Payer Perspective: Digital Therapeutics Validation
Mark Bini, Vice President, Innovation and Member Experience, EXPRESS SCRIPTS

12:50PM – 1:50PM

Luncheon

1:50PM – 2:30PM

Data and Privacy: Who Owns the Data and What Can They Do With It?
Melissa Liu, Senior Director, Operations, Privacy, Security, GLOOKO

2:30PM – 3:10PM

Real-World Evidence: Understand the Value of Developing RWE in Digital Therapeutics
Veera Anantha, Founder, CTO and President, THE LEARNING CORP

3:50PM – 4:00PM

Co-Chairpersons’ Closing Remarks
Joel Sangerman, Chief Commercial Officer, CLICK THERAPEUTICS
Ruchita Sinha, Former Senior Director of Investments, SANOFI VENTURES